Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Katznelson

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Clinical Transplants|January 1, 1994
Primary disease effects and associationsS Katznelson, J McClelland, J M Cecka
Clinical Transplants|January 1, 1997
Clinical aspects of sensitizationS Katznelson, S Bhaduri, J M Cecka
The Journal of Infectious Diseases|July 1, 1984
Efficacy of the condom as a barrier to the transmission of cytomegalovirusS Katznelson, W L Drew, L Mintz
Clinical Transplants|January 1, 1995
The effect of race and ethnicity on kidney allograft outcomeS Katznelson, D W Gjertson, J M Cecka
Transplantation Proceedings|June 24, 1998
Pravastatin and cyclosporine inhibit platelet-derived growth factor-stimulated vascular smooth muscle cell mitogenesis: an investigation of mechanismsS Katznelson, A Ramirez, R Perez, et al.
Transplantation Proceedings|June 24, 1998
Cyclosporine A-associated thrombotic thrombocytopenic purpura following lung transplantationP Roberts, D Follette, R Allen, et al.
Transplantation Proceedings|June 24, 1998
HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activationS M Rudich, P K Mongini, R V Perez, et al.
Transplantation Proceedings|October 1, 1994
Cyclosporine-induced hemolytic uremic syndrome: factors that obscure its diagnosisS Katznelson, A Wilkinson, T R Rosenthal, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Fluvastatin in combination with RAD significantly reduces transplant coronary vasculopathy in rat cardiac allograftsC R. Gregory, S Katznelson, S M. Griffey, et al.
Transplantation|October 2, 2001
Fluvastatin in combination with rad significantly reduces graft vascular disease in rat cardiac allograftsC R Gregory, S Katznelson, S M Griffey, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Clinical Transplants|January 1, 1994
Primary disease effects and associationsS Katznelson, J McClelland, J M Cecka
Clinical Transplants|January 1, 1997
Clinical aspects of sensitizationS Katznelson, S Bhaduri, J M Cecka
The Journal of Infectious Diseases|July 1, 1984
Efficacy of the condom as a barrier to the transmission of cytomegalovirusS Katznelson, W L Drew, L Mintz
Clinical Transplants|January 1, 1995
The effect of race and ethnicity on kidney allograft outcomeS Katznelson, D W Gjertson, J M Cecka
Transplantation Proceedings|June 24, 1998
Pravastatin and cyclosporine inhibit platelet-derived growth factor-stimulated vascular smooth muscle cell mitogenesis: an investigation of mechanismsS Katznelson, A Ramirez, R Perez, et al.
Transplantation Proceedings|June 24, 1998
Cyclosporine A-associated thrombotic thrombocytopenic purpura following lung transplantationP Roberts, D Follette, R Allen, et al.
Transplantation Proceedings|June 24, 1998
HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activationS M Rudich, P K Mongini, R V Perez, et al.
Transplantation Proceedings|October 1, 1994
Cyclosporine-induced hemolytic uremic syndrome: factors that obscure its diagnosisS Katznelson, A Wilkinson, T R Rosenthal, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Fluvastatin in combination with RAD significantly reduces transplant coronary vasculopathy in rat cardiac allograftsC R. Gregory, S Katznelson, S M. Griffey, et al.
Transplantation|October 2, 2001
Fluvastatin in combination with rad significantly reduces graft vascular disease in rat cardiac allograftsC R Gregory, S Katznelson, S M Griffey, et al.
Pageof 4